Image credit: Canva
Prostate cancer is one of the most common cancers in American men; men of African ancestry have a higher rate of the disease and a higher likelihood of death when compared to men of European ancestry. Researchers want to find better screening methods to improve the detection of prostate cancer in African American men. A clinical trial led by Ismail Baris Turkbey, M.D., Senior Clinician in the Molecular Imaging Branch, seeks to improve diagnostic outcomes for prostate cancer in African American adults by testing new imaging technology.
The trial will take place at the NIH Clinical Center in Bethesda, Maryland, and there is no cost for participation.
For more information, please contact Yolanda McKinney, R.N., (240) 760-6095 or ymckinney@nih.gov
Clinicaltrials.gov identifier: NCT05872503
NCI Protocol ID: IRB001567
Official Title: Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy
The Center for Cancer Research is NCI’s internal cancer center, a publicly funded organization working to improve the lives of cancer patients by solving important, challenging and neglected problems in cancer research and patient care. Highly trained physician-scientists develop and carry out clinical trials to create the medicines of tomorrow, treating patients at the world’s largest dedicated research hospital on the campus of the National Institutes of Health in Bethesda, Maryland.
For more information on CCR clinical trials click here, and subscribe to have the latest CCR clinical trials sent directly to your inbox.